Oric Pharmaceuticals Inc. (ORIC) Social Stream
ORIC PHARMACEUTICALS INC (ORIC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ORIC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $52 | $31 | $39.333 | $5.63 | 598.63% |
| 2022-01-26 | 6 | $52 | $31 | $38.166 | $5.63 | 577.9% |
| 2022-03-22 | 7 | $45 | $7 | $26 | $5.63 | 361.81% |
| 2022-04-04 | 6 | $33 | $10 | $19 | $5.63 | 237.48% |
| 2022-05-11 | 6 | $17 | $10 | $13.666 | $5.63 | 142.74% |
| 2022-08-12 | 6 | $17 | $10 | $14 | $5.63 | 148.67% |
| 2022-11-08 | 6 | $15 | $10 | $12.5 | $5.63 | 122.02% |
| 2022-12-09 | 6 | $16 | $10 | $13.666 | $5.63 | 142.74% |
The Trend in the Analyst Price Target
Over the past 25 months, ORIC's average price target has gone down $31.5.
ORIC reports an average of 310.16% for its upside potential over the past 37 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-22 | 7 | 33 | 7 | 18.000 | 4.76 | 278.15% |
| 2022-03-22 | 7 | 45 | 7 | 26.000 | 4.76 | 446.22% |
| 2022-03-22 | 6 | 45 | 7 | 26.000 | 4.76 | 446.22% |
| 2022-04-20 | 6 | 17 | 10 | 13.666 | 3.89 | 251.31% |
| 2022-05-11 | 6 | 17 | 10 | 13.666 | 2.73 | 400.59% |
ORIC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 3 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
ORIC's average broker recommendation rating worsened by 0.67 over the prior 48 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ORIC PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 958.66% of all US stocks.
- ORIC PHARMACEUTICALS INC's average analyst price target is greater than 289.94% of all US stocks.
- In terms of how ORIC PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -668.57% of that group.
- In the context of stocks in the small market cap category, ORIC PHARMACEUTICALS INC's number of analysts covering the stock is higher than 860.66% of them.
Stocks similar to ORIC PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PLRX, CALT, and RNA.
View All Top Stocks by Price Target
What is the outlook for ORIC? Use POWR Ratings for clearer insight into price direction.